-+ 0.00%
-+ 0.00%
-+ 0.00%

LARIMAR THERAPEUTICS, INC. : LEERINK PARTNERS ASSUMES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $13 VS $12

Reuters·09/14/2026 10:04:49

Please log in to view news